Bortezomib just for induction or also for maintenance in myeloma patients with renal impairment?
Keywords: 
Bortezomib
Multiple myeloma
Humans
Antineoplastic agents
Issue Date: 
Jan-2014
Publisher: 
Ferrata Storti Foundation
ISSN: 
0390-6078
Citation: 
San Miguel JF. Bortezomib just for induction or also for maintenance in myeloma patients with renal impairment?. Haematologica. 2014 Jan;99(1):5-6
Abstract
Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial.

Files in This Item:
Thumbnail
File
0990005.pdf
Description
Size
104.79 kB
Format
Adobe PDF


Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.